Greendiamz Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 103.35 Cr
- Revenue Growth 149.63%
- Profit Growth 68.31%
- Ebitda 132.72%
- Net Worth -5.20%
- Total Assets -2.88%
About Greendiamz Biotech
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U36990GJ2009PLC056869
-
Company No.
056869
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
08 May 2009
-
Date of AGM
27 Sep 2017
-
Date of Balance Sheet
31 Mar 2017
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Greendiamz Biotech Limited offer?
Greendiamz Biotech Limited offers a wide range of products and services, including Biodegradable and Compostable Bags, Biodegradable Garbage Bags, Compostable Garbage Bag.
Who are the key members and board of directors at Greendiamz Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kapilkumar Narendra
|
Director | 25-Mar-2013 | Current |
|
Deepak Sanghvi
|
Director | 08-May-2009 | Current |
|
Champat Sanghvi
|
Director | 08-May-2009 | Current |
Financial Performance of Greendiamz Biotech.
Greendiamz Biotech Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 149.63% increase. The company also saw a substantial improvement in profitability, with a 68.31% increase in profit. The company's net worth dipped by a decrease of 5.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greendiamz Biotech?
In 2017, Greendiamz Biotech had a promoter holding of 92.40% and a public holding of 7.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Greendiam Exim Private LimitedDeepak Sanghvi and Champat Sanghvi are mutual person
Charges (Loans)
₹103.35 Cr
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 103.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2012 | Union Bank Of India | ₹6.40 Cr | Open |
| 15 Dec 2011 | Union Bank Of India | ₹48.49 Cr | Open |
| 26 Sep 2009 | Union Bank Of India | ₹48.46 Cr | Open |
How Many Employees Work at Greendiamz Biotech?
Greendiamz Biotech has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greendiamz Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greendiamz Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
